AGENDA

The REPRISE III Pivotal IDE Trial with the Lotus Valve: An Investigator’s Insight
Ted Feldman, MD

Discussion

REPRISE III Secondary Endpoints in Perspective and the Path Ahead for the Lotus Valve
Michael Reardon, MD

Discussion: The Complementary Use of Multiple TAVI Systems to Optimally Treat the Broadest Population of Aortic Stenosis Patients
Martin Leon, MD, Michael Reardon, MD, & Ted Feldman, MD